top of page
Search Results
All (4)
Posts (2)
Other Pages (2)
Results found for "Explicyte"
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance development of new drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology (IO), and Explicyte
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
interconnected nodes which learn hierarchical representations of the data, eliminating the need for explicit
bottom of page